CLINICAL TRIALS PROFILE FOR PROMAZINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for PROMAZINE HYDROCHLORIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03457311 ↗ | Clinical Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution®) | Unknown status | Richever Enterprise Co., Ltd. | Phase 3 | 2013-09-09 | The primary objective is to determine the oral galactose single point (OGSP) cutoff values to discriminate subjects with different hepatic function. The secondary objective is to analyze the correlations between OGSP and other hepatic function assessment methods among this trial subjects. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PROMAZINE HYDROCHLORIDE
Condition Name
Clinical Trial Progress for PROMAZINE HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for PROMAZINE HYDROCHLORIDE
Sponsor Name